Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function

US Patent 11434296 · Granted Sep 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Signature of TL1A (TNFSF15) signaling pathway2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025
Methods of selecting, based on polymorphisms, an inflammatory bowel disease subj2025
Diagnosis and treatment of inflammatory bowel disease2024
Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel2024
Kit comprising contiguous nucleobases, including position 76, of RS57459942024